Navigation Links
Genoptix Announces Participation at Lehman Brothers 11th Annual Global Health Care Conference
Date:3/7/2008

CARLSBAD, Calif., March 7 /PRNewswire-FirstCall/ -- Genoptix, Inc. (Nasdaq: GXDX), a specialized laboratory services provider, today announced the company's participation in the 11th Annual Lehman Brothers Global Health Care Conference at the Loews Miami Beach Hotel in South Beach, Fla., March 18 - 20, 2008.

Dr. Tina Nova Bennett, President and CEO of Genoptix, and Sam Riccitelli, COO, will present at the conference on Tuesday, March 18, 2008 beginning at approximately 10:45am EDT. They will provide an overview of the company's specialized diagnostic laboratory services business, growth strategies and 2007 financial results.

The presentation is expected to last approximately 30 minutes, followed by a short question and answer session, all of which will be webcast live on the Internet and accessible through the investor relations section of the Genoptix website at http://www.genoptix.com. Listeners should go to this site at least 15 minutes prior to the event to register, download and install any necessary software. A replay will also be available for 30 days following the initial presentation webcast.

About Genoptix, Inc.

Genoptix is a specialized laboratory service provider focused on delivering personalized and comprehensive diagnostic services to community-based hematologists and oncologists. Genoptix is headquartered in Carlsbad, California.

Forward-Looking Statements

This press release contains forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements. Actual results may differ materially from those projected. Genoptix dis
'/>"/>

SOURCE Genoptix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Genoptix Announces Participation at Cowen and Company 28th Annual Health Care Conference
2. Genoptix Announces Pricing of Secondary Public Offering
3. Genoptix Announces Filing of Registration Statement for Secondary Public Offering of Common Stock
4. Genoptix Reports Strong Financial Results for the Fourth Quarter and Full Year 2007
5. Genoptix, Inc. to Announce Fourth Quarter and Full Year 2007 Financial Results on February 12, 2008
6. Genoptix, Inc. Announces Pricing for Initial Public Offering
7. Susan G. Komen for the Cure(R) Announces Global Promise Fund to Help Women Worldwide
8. ACS Announces $57 Million Contract With Missouri HealthNet
9. Nfocus Neuromedical Announces Acquisition of StarFire Medical
10. QED International Associates Announces Changes to the HealthShares(TM) Composite and HealthShares(TM) Cancer Indexes
11. Pharos Innovations Announces First Recipient of National Award for Achievements in Chronic Care Programs and Research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2009)...ep eating under control, expert says , ,...eason means you,ll be faced with a seemingly endle...mply give in and eat too much, others deny themsel... navigate between overindulgence and deprivation, ...onsult Services at Brigham and Women,s Hospital in...
(Date:11/22/2009)...The holiday season is filled with get-togethers wi...us. It can also be stressful and tiring at times. ...igue, and high fat foods -- factors that can, over...e National Foundation for Cancer Research has deve...ure a happier, more healthful holiday season, and ...
(Date:11/22/2009)... 21 Congressman Chaka F...he United States Senate,s vote tonight to proceed ..., "Senators Arlen Specter and Bob Casey deserve...ns for casting stand-up, critical votes in the Sen...ffordable Health Care Reform legislation to full d...
(Date:11/21/2009)...v. 21 DNC Chairman Tim ...ate voted to begin full debate of health insurance...scom.com/cgi-bin/prnh/20080519/DNCLOGO ) ,, "...e road to enacting health insurance reform. By cle...now have an opportunity to debate the health refor...
(Date:11/21/2009)... 21 Milvia Lopez, by her attorney ...y filed suit, in Supreme Court, New York County, b...that while Ms. Lopez underwent a routine transesop...SPITAL , doctors used an HIV infected scope exposi...several hours after being discharged from the proc...
Breaking Medicine News(10 mins):Health News:Go Healthy, Not Hungry for Holiday Eating 2Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 2Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 3Health News:Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 2Health News:Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure 2
...ep in understanding how the nervous system and the...in Institute for Medical Research have identified ...the spleen communicate. , ...nstein Institute for Medical Research have identi...
...to safety; group seeks legislative help , ...y can be nearly silent, hybrid cars pose a serious...impaired people, says the American Council of the ...sually impaired learn to rely on their hearing and...
...thocyanidins are natural, plant-based color...Calif., July 21 ChromaDex Corp., (OTC,Bulletin Bo...ndards and,contract research, announced today its ... the University at Buffalo (SUNY,Buffalo), to prod...
... Inc, (http://www.inutrition.com ) and InterACTIVE...com ) subsidiaries of Natural Nutrition, Inc, (OTC...mpanies have inked an,agreement with actor John O,...rnet video campaign. Mr. O,Hurley is bringing,his ...
...c and Orthopedic Hospital of Chicago offers inform.... Available as a laminated card or downloadable p...sks, including knee-specific strengthening exercis...ament (ACL) every year. That's double the nu...
...ss surgery, researchers say , , FRIDAY, Ju...e grown in mice the kind of functioning heart bloo... operations. , One ultimate goal is to replace som... hearts that need more oxygen, said Juan M. Melero...
Other Medicine News:Health News:Embargoed Until Monday, July 21 at 5 p.m. EST; Scientists Figure Out How the Immune System and Brain Communicate to Control Disease 2Health News:Embargoed Until Monday, July 21 at 5 p.m. EST; Scientists Figure Out How the Immune System and Brain Communicate to Control Disease 3Health News:Hybrid Cars Pose Risk to Blind, Visually Impaired 2Health News:ChromaDex Licenses Green Chemistry Technology to Manufacture a New Class of Super Fruit Compounds 2Health News:ChromaDex Licenses Green Chemistry Technology to Manufacture a New Class of Super Fruit Compounds 3Health News:iNutrition Signs John O'Hurley to Launch New Internet Video Campaign 2Health News:Complimentary Sports Injury Prevention Pamphlet for Women Offered by NOHC of Chicago 2Health News:Complimentary Sports Injury Prevention Pamphlet for Women Offered by NOHC of Chicago 3Health News:Heart Blood Vessels Grown in the Lab 2
(Date:11/20/2009)...wswire-FirstCall/ -- Biotel Inc. (OTC Bulletin Boa...ended September 30, 2009 with net earnings of $128...3,263,000. This compares to net earnings of $328,...,168,000 for the first quarter of last year. ,,...resident and CEO Steve Springrose said: "Biotel en...
(Date:11/20/2009)... Smith & Nephew ( SNN...ounce the signing of a technology development cont...that may lead to the creation of a fracture fixati...of the limbs of soldiers who sustain battlefield i...earch Projects Agency (DARPA), the central researc...
(Date:11/19/2009)...Newswire/ -- In response to an ever-increasing num...dicines, Operation Pangea II, involving 24 countri...th Organization,s International Medical Products A... the dangers of buying medicines online. ,, The...of arrests and the seizure of thousands of potenti...
Breaking Medicine Technology:Biotel Announced Profitable First Quarter Ended September 30, 2009 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2Dynatronics Will Request Hearing With Nasdaq Regarding Listing Status 5522 1Paradigm shift needed to combat drug resistance 59596 1Paradigm shift needed to combat drug resistance 59596 2Physical therapists play integral role in prevention risk reduction and treatment of lymphedema 59594 1Physical therapists play integral role in prevention risk reduction and treatment of lymphedema 59594 2Physical therapists play integral role in prevention risk reduction and treatment of lymphedema 59594 3
...hase II Results of Roche and Ipsen,s First Once-We...betes Association Meeting -, NUTLEY, N.J., June 1...es drug taspoglutide (R1583) has been shown to pro...nd weight loss after only,eight weeks of treatment...supports entry into Phase III. Taspoglutide, origi...
...l Results Expected in Q3 2008, Conference Call to...ern Time, MOUNTA...nc. (Nasdaq: ALXA ) announced today that it has c...trial with AZ-004 (Staccato(R),loxapine). AZ-004 i...for,the treatment of acute agitation in patients w...
Other Medicine Technology:Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 2Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 3Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 4Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 5Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 6Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 2Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 3Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 4Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 5Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 6Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 7
Straight Iris Scissors (Ring Handle)
Surpass Superfusion
...es its hallmark 50 and 100 ms scans to perform tru...scan protocols and proprietary cardiac analysis so...targets and two x-ray detector rings to image the ...ial perfusion and wall motion. The EBT C300 also s...
Corneal Scissors (Westcott Straight Tenotomy Scissors)
Medicine Products: